Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxel
about
Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gpRNA disruption is associated with response to multiple classes of chemotherapy drugs in tumor cell lines.Reduced accumulation of platinum drugs is not observed in drug-resistant ovarian cancer cell lines derived from cisplatin-treated patientsSTAT1-associated intratumoural TH1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer.Nanoceria-mediated delivery of doxorubicin enhances the anti-tumour efficiency in ovarian cancer cells via apoptosis.Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance
P2860
Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxel
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Distinct genetic alterations o ...... e to carboplatin and docetaxel
@ast
Distinct genetic alterations o ...... e to carboplatin and docetaxel
@en
type
label
Distinct genetic alterations o ...... e to carboplatin and docetaxel
@ast
Distinct genetic alterations o ...... e to carboplatin and docetaxel
@en
prefLabel
Distinct genetic alterations o ...... e to carboplatin and docetaxel
@ast
Distinct genetic alterations o ...... e to carboplatin and docetaxel
@en
P2093
P2860
P356
P1476
Distinct genetic alterations o ...... e to carboplatin and docetaxel
@en
P2093
Amadeo M Parissenti
Baoqing Guo
Carita Lannér
Katherine L McCallum
Rashmi Narendrula
Stephanie Cull
Stephen R Armstrong
P2860
P2888
P356
10.1186/1757-2215-5-40
P577
2012-11-30T00:00:00Z
P5875
P6179
1011450756